PODD — INSULET CORP
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1145197 ·
Last close
$145.34
Market Cap
$10.08B
52W High
$354.88
52W Low
$126.40
ADV30
1,404,505
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 842,000,000 | 632,100,000 | 189,800,000 | 141,100,000 | 3,415,100,000 | 584,400,000 | 1,836,000,000 |
| Jun 2026 | 801,700,000 | 562,600,000 | 129,700,000 | 95,000,000 | 3,165,100,000 | 534,900,000 | 1,742,900,000 |
| Mar 2026 | 761,700,000 | 529,100,000 | 122,200,000 | 91,100,000 | 2,987,200,000 | 480,400,000 | 1,684,600,000 |
| Dec 2025 | 783,800,000 | 568,600,000 | 146,300,000 | 101,600,000 | 3,190,400,000 | 716,100,000 | 1,675,100,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$509,000,000
Investing CF
$-284,600,000
Financing CF
$-394,300,000
CapEx
$-276,400,000
Dividends Paid
—
Buybacks
$-300,000,000
EPS Diluted TTM
$6.14
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$614,500,000
Inventory
$552,100,000
Receivables
$689,000,000
ST Investments
—
EBIT TTM
$608,400,000
Pretax Income TTM
$549,100,000
Interest Exp TTM
$59,300,000
Analysts
23
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,189,199,872
EBITDA
$693,299,968
Free Cash Flow
$113,512,496
Enterprise Value
$10,617,551,872
Total Cash
$584,400,000
Total Debt
$1,038,400,000
Shares Out
69,371,043
Trailing EPS
$6.12
Book Value
$22.76
ROE
28.9%
ROA
11.4%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,708,100,000 | 473,800,000 | 247,100,000 | 3,190,400,000 | — | 1,515,300,000 | 569,300,000 |
| Dec 2024 | 2,071,600,000 | 308,900,000 | 418,300,000 | 3,087,700,000 | 1,876,100,000 | 1,211,600,000 | 430,200,000 |
| Dec 2023 | 1,697,100,000 | 220,100,000 | 206,300,000 | 2,588,200,000 | 1,855,500,000 | 732,700,000 | 145,700,000 |
| Dec 2022 | 1,305,300,000 | 37,600,000 | 4,600,000 | 2,251,100,000 | 1,774,700,000 | 476,400,000 | 119,000,000 |
| Dec 2021 | — | — | — | — | 1,492,500,000 | — | — |
TTM Snapshot
Revenues TTM
$3,053,400,000
NetIncome TTM
$375,300,000
OpCashFlow TTM
—
Assets (Latest)
$3,165,100,000
Forward EPS
$7.90
Max Pain — expiry 2026-12-18
max pain strike: $150.00 · spot: $139.98 · call oi: 3,191 · put oi: 3,837
Expected Move to 2026-12-18:
±$14.35
(10.25%) —
implied range
$125.63 –
$154.33
· ATM straddle on $140.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ALGN | ALIGN TECHNOLOGY INC | $11.52B | $163.46 | — |
| PEN | Penumbra Inc | $12.58B | $319.11 | — |
| SNN | SMITH & NEPHEW PLC | $12.77B | $30.51 | — |
| SNNUF | SMITH & NEPHEW PLC | $12.93B | $15.45 | — |
| GMED | GLOBUS MEDICAL INC | $7.72B | $69.99 | — |
News headlines (Yahoo Finance, 1h cache)
Insulet downgraded, Tandem Diabetes upgraded: Wall Street's top analyst calls
2026-11-18 14:35 · Yahoo
Can Insulet Stock Jump 50%?
2026-11-16 23:20 · Yahoo
Insulet (PODD) Just Overtook the 20-Day Moving Average
2026-11-12 13:35 · Yahoo
Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes"
2026-11-10 19:42 · Yahoo
For World Diabetes Day, Insulet Launches "Give Yourself the Freedom to" Campaign, Encouraging People with Diabetes to Prioritize Their Well-Being
2026-11-09 12:00 · Yahoo
Insulet (PODD) Stock May Be 36% Undervalued Despite $1b Buyback
2026-11-05 23:20 · Yahoo
Insulet Stock What’s Changed After Earnings Beat
2026-11-05 05:24 · Yahoo
Insulet Corp (PODD) Q3 2026 Earnings Call Highlights: Revenue Up 19%, EPS Jumps 60% and $1 ...
2026-11-05 03:06 · Yahoo
What Insulet (PODD) Said on Its Q3 Earnings Call
2026-11-04 19:14 · Yahoo
Insulet Corporation Q3 2026 Earnings Call Summary
2026-11-04 18:29 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.